CC
AGN.PRA

Cannell & Co’s Allergan plc AGN.PRA Stock Holding History

Cannell & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,668
Closed -$978K – 266
2017
Q4 		$978K Sell
1,668
-23,835
-93% -$15.4M 0.03% 169
2017
Q3 		$18.8M Buy
25,503
+5,252
+26% +$4.36M 0.65% 49
2017
Q2 		$17.6M Buy
20,251
+1,353
+7% +$1.13M 0.61% 57
2017
Q1 		$16.1M Buy
18,898
+370
+2% +$307K 0.57% 57
2016
Q4 		$14.1M Sell
18,528
-2,424
-12% -$1.83M 0.51% 66
2016
Q3 		$17.2M Buy
20,952
+1,077
+5% +$931K 0.63% 57
2016
Q2 		$16.6M Buy
19,875
+14,921
+301% +$12.5M 0.6% 54
2016
Q1 		$4.55M Buy
+4,954
New +$4.74M 0.16% 103
2015
Q4 		– Sell
-14,897
Closed -$14.1M – 275
2015
Q3 		$14.1M Sell
14,897
-269
-2% -$281K 0.46% 61
2015
Q2 		$15.9M Buy
+15,166
New +$15.9M 0.45% 59

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Cannell & Co's AGN.PRA Position: Q1 2018 in Review

Cannell & Co sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,668 shares — an estimated $978K sold.

Cannell & Co first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $18.8M in Q3 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Cannell & Co reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Cannell & Co sold 1,668 Allergan plc shares in Q1 2018, an estimated $978K.
  • Cannell & Co first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Cannell & Co's Allergan plc position peaked at $18.8M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Cannell & Co's 13F filing for Q1 2018, filed 9 May 2018.